Sickle cell anaemia is one of the major hereditary health problems in tropical Africa where the sickle cell gene frequency is particularly high. The disease occurs with high incidence in west, east, and central Africa and this has been related to the prevalence of malaria in these regions. The classic hallmarks of sickle cell anaemia are reccurrent episodes of vasoocclusive crises often with multiorgan manifestations and a chronic haemolytic anaemia. Because of the hereditary nature of the disease patients with sickle cell anaemia are particularly symptomatic during childhood and in Africa many affected children do not survive to adulthood.
Most children with sickle cell anaemia maintain a haemoglobin concentration of between 7 and 8 5 g/dl in the steady state. This is achieved through a fairly precise balance of accelerated rate of red blood cell destruction and a greatly increased marrow erythropoietic activity. Episodes of severe anaemia, which may be life threatening, do occur, however, particularly in children. These have been alluded to as haematologic or anaemic crises as distinct from vasoocclusive crises and are usually due to a temporary failure of bone marrow erythrocyte production (aplastic crisis), a splenic sequestration crisis, or a so called hyperhaemolytic crisis. The latter implies an enhanced destruction of sickle red blood cells beyond that which pertains in the steady state-that is, above the pre-crisis value. This is thought by many to occur rarely. 1-3 Table 1 ). Depression of erythropoiesis was the main bone marrow finding in 14 of the 33 children. The depression of erythropoiesis was profound in 11 children and moderate in three. This corresponded with a myeloid:erythroid ratio ranging from 16:1 to 200:1 in those whose bone marrow was considered to show profound erythroid hypoplasia and 5:1 in the remaining three children who exhibited less severe hypoplasia. Haemoglobin concentrations in these 14 children with erythroid hypoplasia ranged from 2 g/dl to 4-6 g/dl, with a mean of 3-1 g/dl.
Stainable iron was absent in the marrows of four of the 11 children with erythroid hypoplasia and was reduced in another three. Megaloblastic changes could not be assessed in this group of children since the degree of erythroid hypoplasia made such evaluation uncertain.
Erythroid hyperplasia. (Table 2 ). Erythroid hyperplasia was the major finding of marrow examination in 17 children. Myeloid:erythroid ratios ranged from 1:1 to 1:3-5 in these children and the mean haemoglobin concentration on admission was 4 g/dl, ranging from 2-8 to 4*9 g/dl. Stainable iron was absent in the marrows of 10 of the 17 children and was reduced in two. One patient had increased stainable iron in the marrow. Changes consistent with megaloblastic haematopoiesis were present in 8 marrows. These changes were notable in three and were judged to be moderate in five patients.
Two patients (aged 6 and 7 years) were clinically diagnosed to have splenic sequestration crises on the basis of severe anaemia (haemoglobin 2-6 and 1-4 g/dl) and noticeable sudden enlargement of the spleen. Bone marrow in both showed erythroid hyperplasia. Erythropoiesis was noticeably megaloblastic in one and no stainable iron was present in the marrow of the other.
Two boys were found to have glucose-6-phosphate dehydrogenase deficiency; the bone marrows showed erythroid hyperplasia in both.
Discussion
Forty four per cent of children with sickle cell anaemia presenting with severe anaemia in our series were classified as having aplastic crises on the (Table 1) . Our experience and that of others-6 strongly suggest that infections-viral, bacterial, or plasmodial-are generally the major precipitating events in the development of aplastic crises in sickle cell patients. Transient failure of erythropoiesis in these patients may result from some toxic or inhibitory effect of these infective agents on precursor red cells. This concept has been given added support by recent reports that sera containing parvolike viruses could inhibit haematopoietic progenitor colony formation in vitro.8 9 Where facilities are available (either electronmicroscopy or serology, or both) evidence of infection by these agents should now be sought to relate and define clearly their clinical role and importance to aplastic crises in populations where the frequency of sickle cell anaemia is high.
In 17 of the 33 children who presented with anaemic crises, bone marrow evaluation showed erythroid hyperplasia with myeloid:erythroid ratios ranging from 1:1 to 1:3-5. Since the marrow of sickle cell patients manifests erythroid hyperplasia in the steady state its finding in an acute anaemic crisis is more difficult to interpret. Acute severe anaemia in the presence of marrow erythroid hyperplasia may suggest an increased rate of haemolysis superimposed on an already existing, chronic haemolytic anaemia-the so called hyperhaemolytic crisis. The frequency of a hyperhaemolytic crisis in sickle cell anaemia is, however, controversial. Maclver and Parker-Williams2 suggest that this type of crisis occurs rarely, if ever, in sickle cell anaemia and a similar view is expressed by Diggs.3 Mann et al,1) however, in a study of 16 episodes of acute anaemia necessitating urgent transfusion in 13 children with sickle cell anaemia presented evidence for increased haemolysis in five patients. This was based on findings of increased serum bilirubin concentrattons, increased or maintained reticulocyte counts, and the presence of methaemalbuminaemia. That accelerated haemolysis is possible in sickle cell patients with glucose-6-phosphate dehydrogenase deficiency has also been well documented. " On the other hand marrow erythroid hyperplasia in the presence of severe anaemia could represent the early recovery phase from aplastic crisis when delivery of red cells in any quantity into the circulation has not yet begun.2 Unfortunately reticulocyte counts were not available on all our patients on admission but 7 patients with marrow erythroid hyperplasia and severe anaemia in whom reticulocyte counts were available all had values between 2% and 6%. Such relatively low reticulocyte counts in the presence of erythroid hyperplasia would strongly favour an early recovery phase from aplastic crisis rather than a hyperhaemolytic crisis. Three of the children with severe anaemia and erythroid hyperplasia had malaria parasitaemia and two others had glucose-6-phosphate dehydrogenase deficiency. An accelerated destruction of red blood cells (hyperhaemolytic crisis) is conceivable under these circumstances.
Stainable iron was absent in the bone marrow of 14 of the 33 children with sickle cell anaemia and anaemic crisis. In five others iron stores were reduced. This strongly suggests iron deficiency anaemia as an associated factor in these children who presented with severe anaemia. It also suggests that iron depletion in general may be a relatively common deficiency in many children with sickle cell anaemia in west Africa. Obviously this has considerable clinical and health implications. Iron deficiency anaemia is generally not considered a medical problem in patients who have sickle cell disease. An increased gastrointestinal absorption of iron associated with haemolysis and iron provided by the red cells are thought to provide a sufficient source of iron. That this may not be entirely correct is supported by recent reports of well documented iron deficiency states in patients with sickle cell disease. 12-15 Diet related geographical differences probably exist, however, in relation to the prevalence of iron deficiency in sickle cell patients. The studies by Rao and Sur from India,'2 Oluboyede from Nigeria,'3 and our data would indicate that iron deficiency is relatively common in sickle cell patients from countries where nutritional deficiencies are common. In contrast, Hussain et al'6 have reported higher serum ferritin concentrations in children with sickle cell disease residing in Britain than in normal control children. Ferritin concentrations were so high in some children with sickle cell disease that ferritin concentration monitoring to prevent excessive iron accumulation was suggested.
The conclusive diagnosis of iron deficiency state should normally include estimation of plasma ferritin concentrations, transferrin saturation, and free erythrocyte protoporphyrin values. In many parts of the world, however, where facilities for the determination of the above are not readily available, examination of the bone marrow for haemosiderin remains the most simple, sensitive, and reliable method of judging the iron status.'7
Megaloblastic marrow changes consistent with folate deficiency were present in 8 children whose marrows showed erythroid hyperplasia. Megaloblastic erythropoiesis was not documented in children who presented with hypoplastic marrows, possibly because the degree of suppression of erythropoiesis excluded marrow diagnosis of folate deficiency. Megaloblastic anaemia complicating sickle cell disease has been well documented in the published reports.'82' Folate deficiency in sickle cell disease develops as the requirement for folic acid by an enhanced erythropoietic activity exceeds dietary intake. Previous dose response studies have suggested an abnormally high requirement for folic acid in sickle cell disease. 2" 21 In west Africa, where folate deficiency may be a common nutritional deficiency in children,22 the child with sickle cell disease is particularly at risk from developing megaloblastic anaemia superimposed on his chronic, haemolytic anaemia. Although children attending our sickle cell clinic were routinely prescribed a daily supplementary intake of folic acid (2-5 to 5 mg) and weekly chloroquine as prophylaxis against malaria, it is obvious from our data that a number of patients did not comply fully with these instructions.
Our evaluation of bone marrow in these children presenting with an anaemic crisis indicates a possible need for supplementary iron and folic acid in children with sickle cell disease living in the tropics where deficiencies of these two nutrients are prevalent. Supplementary iron may not be necessary, however, in those children who frequently require transfusion. We would suggest further that in centres where facilities are available, examination of the bone marrow should be undertaken in children with sickle cell anaemia who present with profound anaemia. This simple procedure allows easy assessment of erythroid activity and possible complicating iron and folate deficiencies. 
